Anaptysbio, INC Form 4 insider transactions

Director Hollings Renton of AnaptysBio, Inc. reports the acquisition and disposal of common stock and restricted stock units.

Director Rita Jain disposed of common stock and restricted stock units of AnaptysBio on June 15, 2024, according to a Form 4 filing.

AnaptysBio's CFO, Dennis Mulroy, sold 1,500 shares of common stock at $23.72 per share on May 22, 2024, under a pre-arranged 10b5-1 trading plan.

AnaptysBio CEO Daniel Faga sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).